Benitec Biopharma Ltd (BNTC)

[georgejjl]

I expect that the second dose of TT-034 could show approximately a 10% reduction in the viral load of hepatitis C.

Then this spring the third dose level may show approximately a 31.6% reduction in the viral load of hepatitis C.

The this summer and autumn 2014 I expect that the fourth dose cohort should show a complete eradication of the hepatitis C from trial subjects in the fourth cohort.

Of course there is a planned fifth cohort that is 3.16 times higher than even the fourth cohort. The fifth cohort could be tried if necessary.

Good luck and GOD bless,

George